Psoriasis Clinical Trials in Phoenix, AZ

About Psoriasis Clinical Trials in Phoenix

Psoriasis is a chronic autoimmune skin condition affecting over 8 million Americans, causing cells to build up rapidly on the surface and forming red, scaly patches that can be itchy and painful. Plaque psoriasis accounts for about 80-90% of cases. While current treatments include topical therapies, phototherapy, and biologics like TNF inhibitors (adalimumab, etanercept) and IL-17/IL-23 inhibitors (secukinumab, guselkumab), clinical trials are testing next-generation oral treatments, TYK2 inhibitors, and combination approaches that may offer longer remission periods with fewer side effects. Patients with moderate-to-severe psoriasis who have not responded adequately to existing therapies are often sought for clinical trial enrollment.

There are currently 10 psoriasis clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 6,569 participants. Research is being sponsored by Bristol-Myers Squibb, Takeda, MoonLake Immunotherapeutics AG and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.